Eirini Kyrmanidou, Christina Kemanetzi, Chatzopoulos Stavros, Myrto-Georgia Trakatelli, Aikaterini Patsatsi, Xenia Madia, . . . Elizabeth Lazaridou. (2024). A Real-Life 208 Week Single-Centred, Register-Based Retrospective Study Assessing Secukinumab Survival and Long-Term Efficacy and Safety Among Greek Patients With Moderate to Severe Plaque Psoriasis, Including Difficult-to-Treat Manifestations Such as Genitals and Scalp. Mattioli1885.
Chicago Style (17th ed.) CitationEirini Kyrmanidou, et al. A Real-Life 208 Week Single-Centred, Register-Based Retrospective Study Assessing Secukinumab Survival and Long-Term Efficacy and Safety Among Greek Patients With Moderate to Severe Plaque Psoriasis, Including Difficult-to-Treat Manifestations Such as Genitals and Scalp. Mattioli1885, 2024.
MLA (9th ed.) CitationEirini Kyrmanidou, et al. A Real-Life 208 Week Single-Centred, Register-Based Retrospective Study Assessing Secukinumab Survival and Long-Term Efficacy and Safety Among Greek Patients With Moderate to Severe Plaque Psoriasis, Including Difficult-to-Treat Manifestations Such as Genitals and Scalp. Mattioli1885, 2024.